Tumour blood flow for prediction of human prostate cancer aggressiveness: a study with Rubidium-82 PET, MRI and Na(+)/K(+)-ATPase-density

PURPOSE: Tumour blood flow (TBF) is a crucial determinant of cancer growth. Recently, we validated Rubidium-82 ((82)Rb) positron emission tomography (PET) for TBF measurement in prostate cancer (PCa) and found TBF and cancer aggressiveness positively correlated. The aims of the present study were to...

Descripción completa

Detalles Bibliográficos
Autores principales: Jochumsen, Mads Ryø, Sörensen, Jens, Pedersen, Bodil Ginnerup, Nyengaard, Jens Randel, Krag, Søren Rasmus Palmelund, Frøkiær, Jørgen, Borre, Michael, Bouchelouche, Kirsten, Tolbod, Lars Poulsen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835182/
https://www.ncbi.nlm.nih.gov/pubmed/32808078
http://dx.doi.org/10.1007/s00259-020-04998-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835182/
https://www.ncbi.nlm.nih.gov/pubmed/32808078
http://dx.doi.org/10.1007/s00259-020-04998-2

Ejemplares similares